Mayo Clinic Evelo Biosciences, Inc. Transaction History

Mayo Clinic

  • $2.86 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 09, 2023
SELL
$0.08 - $3.25 $36,533 - $1.48 Million
-456,665 Reduced 95.29%
22,577 $73,000
Q1 2021

May 13, 2021
SELL
$9.71 - $18.6 $55,453 - $106,224
-5,711 Reduced 1.18%
479,242 $5.13 Billion
Q4 2019

Feb 12, 2020
BUY
$3.81 - $7.45 $1.85 Million - $3.61 Million
484,953 New
484,953 $1.97 Million

About Evelo Biosciences, Inc.

EVLO Quotes by TradingView
  • Ticker EVLO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,994,000
  • Description
  • Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hy...
More about EVLO
Track This Portfolio

Track Mayo Clinic Portfolio

Follow Mayo Clinic and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mayo Clinic, based on Form 13F filings with the SEC.

News

Stay updated on Mayo Clinic with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email